πŸ‡ΊπŸ‡Έ FDA
Patent

US 10717720

Modified compound of andrographolide

granted A61KA61K31/357A61K31/436

Quick answer

US patent 10717720 (Modified compound of andrographolide) held by Medshine Discovery Inc. expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/357, A61K31/436, A61P, A61P11/00